Maze Therapeutics, Inc. (MAZE)

Maze Therapeutics Statistics

Total Valuation

MAZE has a market cap or net worth of $1.91 billion. The enterprise value is $1.55 billion.

Market Cap	1.91B
Enterprise Value	1.55B

Important Dates

The next estimated earnings date is Saturday, February 14, 2026, after market close.

Earnings Date	Feb 14, 2026
Ex-Dividend Date	n/a

Share Statistics

MAZE has 48.12 million shares outstanding. The number of shares has increased by 1,176.31% in one year.

Current Share Class	48.12M
Shares Outstanding	48.12M
Shares Change (YoY)	+1,176.31%
Shares Change (QoQ)	+4.53%
Owned by Insiders (%)	1.25%
Owned by Institutions (%)	49.31%
Float	27.05M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	5.04
P/TBV Ratio	5.04
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 17.70, with a Debt / Equity ratio of 0.06.

Current Ratio	17.70
Quick Ratio	17.39
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -52.69% and return on invested capital (ROIC) is -28.89%.

Return on Equity (ROE)	-52.69%
Return on Assets (ROA)	-27.37%
Return on Invested Capital (ROIC)	-28.89%
Return on Capital Employed (ROCE)	-33.65%
Revenue Per Employee	n/a
Profits Per Employee	-$811,664
Employee Count	125
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-275,000
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	36.36
200-Day Moving Average	20.34
Relative Strength Index (RSI)	51.92
Average Volume (20 Days)	447,227

Short Selling Information

The latest short interest is 2.22 million, so 4.62% of the outstanding shares have been sold short.

Short Interest	2.22M
Short Previous Month	2.22M
Short % of Shares Out	4.62%
Short % of Float	8.23%
Short Ratio (days to cover)	5.37

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-134.57M
Pretax Income	-126.41M
Net Income	-101.46M
EBITDA	-131.96M
EBIT	-134.57M
Earnings Per Share (EPS)	-$3.39

Balance Sheet

The company has $383.94 million in cash and $24.18 million in debt, giving a net cash position of $359.75 million or $7.48 per share.

Cash & Cash Equivalents	383.94M
Total Debt	24.18M
Net Cash	359.75M
Net Cash Per Share	$7.48
Equity (Book Value)	379.44M
Book Value Per Share	7.89
Working Capital	369.19M

Cash Flow

In the last 12 months, operating cash flow was -$106.66 million and capital expenditures -$1.37 million, giving a free cash flow of -$108.03 million.

Operating Cash Flow	-106.66M
Capital Expenditures	-1.37M
Free Cash Flow	-108.03M
FCF Per Share	-$2.24

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MAZE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1,176.31%
Shareholder Yield	-1,176.31%
Earnings Yield	-5.30%
FCF Yield	-5.64%

Analyst Forecast

The average price target for MAZE is $41.00, which is 3.09% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$41.00
Price Target Difference	3.09%
Analyst Consensus	Strong Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	7.93%
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

MAZE has an Altman Z-Score of 6.68 and a Piotroski F-Score of 1.

Altman Z-Score	6.68
Piotroski F-Score	1